ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib

Despite the high efficacy of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) patients, some individuals develop resistance due to impaired bioavailability. It has been previously demonstrated that the haplotypes for ATP-binding cassette subfamily B member 1 (ABCB1)with c.1236C>...

Descripción completa

Detalles Bibliográficos
Autores principales: VIVONA, DOUGLAS, LIMA, LUCIENE TEREZINA, RODRIGUES, ALICE CRISTINA, BUENO, CAROLINA TOSIN, ALCANTARA, GREYCE KELLY STEINHORST, BARROS, LUIZA SALDANHA RIBEIRO, DE MORAES HUNGRIA, VANIA TIESTSCHE, CHIATTONE, CARLOS SÉRGIO, DE LOURDES LOPES FERRARI CHAUFFAILLE, MARIA, GUERRA-SHINOHARA, ELVIRA MARIA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961201/
https://www.ncbi.nlm.nih.gov/pubmed/24660038
http://dx.doi.org/10.3892/ol.2014.1857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961201/
https://www.ncbi.nlm.nih.gov/pubmed/24660038
http://dx.doi.org/10.3892/ol.2014.1857

Ejemplares similares